Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Quantitation of Cannabidiol (CBD) in brain regions and plasma following intranasal administration of a CBD nanoformulation.
Journal: Journal of cannabis research
Published: April 27, 2024
Promotion of recovery from Traumatic Brain Injury (TBI) by Granulocyte Colony-Stimulating Factor (G-CSF) treatment requires cannabinoid receptor type 2 activity.
Journal: Journal of cannabis research
Published: April 01, 2024
Key Features in the Design and Function of Nanocarriers for Intranasal Administration of Gene Therapy in Huntington Disease.
Journal: Journal of nanotechnology and nanomaterials
Published: September 25, 2023
Dual-function hybrid nanoparticles with gene silencing and anti-inflammatory effects.
Journal: Nanomedicine (London, England)
Published: April 04, 2022
Measurement of Δ9THC and metabolites in the brain and peripheral tissues after intranasal instillation of a nanoformulation.
Journal: Journal of cannabis research
Published: December 07, 2021
Administration of Δ9-Tetrahydrocannabinol Following Controlled Cortical Impact Restores Hippocampal-Dependent Working Memory and Locomotor Function.
Journal: Cannabis and cannabinoid research
Published: November 08, 2021
Kinetics of HTT lowering in brain of YAC 128 mice following single and repetitive intranasal dosing of siRNA packaged in chitosan-based nanoparticle.
Journal: Journal of drug delivery science and technology
Published: May 20, 2021
Recovery from Traumatic Brain Injury Following Treatment with Δ9-Tetrahydrocannabinol Is Associated with Increased Expression of Granulocyte-Colony Stimulating Factor and Other Neurotrophic Factors.
Journal: Cannabis and cannabinoid research
Published: May 17, 2021
Granulocyte Colony-Stimulating Factor Enhances Brain Repair Following Traumatic Brain Injury Without Requiring Activation of Cannabinoid Receptors.
Journal: Cannabis and cannabinoid research
Published: February 22, 2021
Awareness of Chorea in Huntington's Disease.
Journal: Journal of Huntington's disease
Published: November 11, 2019
Enriched chitosan nanoparticles loaded with siRNA are effective in lowering Huntington's disease gene expression following intranasal administration.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: July 22, 2019
Last Updated: 09/26/2026